{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:58:15Z","timestamp":1790956695062,"version":"4.1.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi261006-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Sex is a well-recognized factor associated with hepatocellular carcinoma (HCC) incidence, but its association with mortality is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between sex and the risk of overall, liver-related, and non\u2013liver-related mortality among patients with HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted among patients with HCC in 17 centers from 5 countries and regions (2000-2023). Male and female patients with HCC who had balanced baseline characteristics via inverse probability of treatment weighting (IPTW) were included, with a propensity score\u2013matched cohort included for sensitivity analyses. Data were analyzed between July 10 and September 8, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Male vs female sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Overall, liver-related, and non\u2013liver-related mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 8594 patients with HCC (mean [SD] age, 63.3 [10.9] years; 6214 male [72.3%]; 5644 Asian [65.7%], 458 Black [5.3%], 615 Hispanic [7.2%], and 1784 White [20.8%]), 4567 were from Asia (53.1%), 6327 had cirrhosis (73.6%), and 6617 had viral etiology (77.0%). In the unmatched cohort, males had a higher overall mortality rate per 100 person-years than females in the total cohort (15.9 [95% CI, 15.3-16.4] vs 13.3 [95% CI, 12.5-14.1];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and in Asian (14.1 [95% CI, 13.5-14.7] vs 11.1 [95% CI, 10.3-12.0];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), Asia region (14.4 [95% CI, 13.6-15.2] vs 10.8 [95% CI, 9.9-11.8];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), cirrhosis (17.6 [95% CI, 16.9-18.3] vs 14.4 [95% CI, 13.5-15.4];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and hepatitis B (13.6 [95% CI, 12.7-14.5] vs 10.0 [95% CI, 8.6-11.5];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and C (15.8 [95% CI, 15.0-16.6] vs 13.4 [95% CI, 12.4-14.6];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) subgroups. In the IPTW-matched cohort, male sex was associated with increased overall mortality in the full cohort (adjusted hazard ratio [aHR], 1.14 [95% CI, 1.05-1.23];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002) and in Asian (aHR, 1.22 [95% CI, 1.10-1.36];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), Asia region (aHR, 1.23 [95% CI, 1.09-1.39];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), cirrhosis (aHR, 1.18 [95% CI, 1.08-1.29];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and viral (aHR, 1.15 [95% CI, 1.05-1.26];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.004) subgroups. Additionally, sex differences varied by liver disease etiology, with male sex having the highest aHR in the association with overall mortality among individuals with alcohol-associated liver disease (aHR, 1.90 [95% CI, 1.02-3.54];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.04), followed by those with hepatitis B (aHR, 1.22 [95% CI, 1.01-1.47];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.04) or C (aHR, 1.13 [95% CI, 1.02-1.26];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03), but there was no association in patients with metabolic dysfunction\u2013associated steatotic liver disease. There was no significant sex difference for non\u2013liver-related mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261006-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, sex disparities in HCC mortality existed but were heterogeneous across ethnic background and liver disease etiologies. These findings support incorporation of sex-based considerations in HCC management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.37313","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:30:22Z","timestamp":1790955022000},"page":"e2637313","source":"Crossref","is-referenced-by-count":0,"title":["Sex Differences in Mortality Among Patients With Hepatocellular Carcinoma"],"prefix":"10.1001","volume":"9","author":[{"given":"Taotao","family":"Yan","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California"},{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"},{"name":"National Regional Infectious Diseases Center, Clinical Research Center for Infectious Diseases of Shaanxi, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lun","family":"Yeh","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leong","sequence":"additional","affiliation":[{"name":"Henry D. Janowitz Division of Gastroenterology, Mount Sinai Health System, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Won","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"},{"name":"Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Henry D. Janowitz Division of Gastroenterology, Mount Sinai Health System, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology of Hepatology, E-Da Cancer Hospital\/I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Landis","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Central Hospital, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Vutien","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Uojima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d\u2019Hebron and Universitat Aut\u00f2noma de Barcelona, Barcelona and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas del Instituto Carlos III, Barcelona, Spain"},{"name":"Liver Diseases Group, Vall d\u2019Hebron Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Trinh","sequence":"additional","affiliation":[{"name":"San Jose Gastroenterology, San Jose, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hao","family":"Tseng","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology of Hepatology, E-Da Cancer Hospital\/I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sola","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Feng","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chien","family":"Tsai","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yen","family":"Dai","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Fu","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Long","family":"Chuang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California"},{"name":"Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California"},{"name":"Department of Epidemiology and Population Health, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"3","key":"zoi261006r1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10504","key":"zoi261006r2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"10360","key":"zoi261006r3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma.","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"10512","key":"zoi261006r4","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.","volume":"406","author":"Collaborators","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"zoi261006r5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14218\/JCTH.2023.00356","article-title":"Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades.","volume":"12","author":"Abboud","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"12","key":"zoi261006r6","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1007\/s12094-025-03965-3","article-title":"Sex and gender disparities in hepatocellular carcinoma: insights into risk, diagnosis, and therapeutic outcomes.","volume":"27","author":"Tran","year":"2025","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"zoi261006r7","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.14309\/ajg.0000000000000643","article-title":"Gender matters: characteristics of hepatocellular carcinoma in women from a large, multicenter study in the United States.","volume":"115","author":"Phipps","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"zoi261006r8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/apt.15917","article-title":"Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.","volume":"52","author":"Rich","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"zoi261006r9","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1097\/TP.0000000000003575","article-title":"Sex-based disparities in hepatocellular carcinoma recurrence after liver transplantation.","volume":"105","author":"Cullaro","year":"2021","journal-title":"Transplantation"},{"issue":"11","key":"zoi261006r10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jamasurg.2024.3498","article-title":"Sex and size disparities in access to liver transplant for patients with hepatocellular carcinoma.","volume":"159","author":"Cron","year":"2024","journal-title":"JAMA Surg"},{"issue":"2","key":"zoi261006r11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cgh.2023.07.029","article-title":"Age-dependent female survival advantage in hepatocellular carcinoma: a multicenter cohort study.","volume":"22","author":"Pang","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi261006r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000107","article-title":"Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study.","volume":"3","author":"Ladenheim","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"issue":"10","key":"zoi261006r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102498","article-title":"Prolonged survival in women with hepatocellular carcinoma: a French observational study.","volume":"48","author":"Busso","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"zoi261006r14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jgh3.12910","article-title":"Gender survival differences in hepatocellular carcinoma: is it all due to adherence to surveillance: a study of 1716 patients over three decades.","volume":"7","author":"Liou","year":"2023","journal-title":"JGH Open"},{"issue":"6","key":"zoi261006r15","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"zoi261006r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100695","article-title":"Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy.","volume":"27","author":"Liang","year":"2022","journal-title":"Ann Hepatol"},{"issue":"11","key":"zoi261006r17","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3390\/cancers15112892","article-title":"Is there really a difference in outcomes between men and women with hepatocellular cancer?","volume":"15","author":"Fa","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"zoi261006r18","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.cgh.2017.05.036","article-title":"Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma.","volume":"15","author":"Hassan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"zoi261006r19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1607374","article-title":"Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy.","volume":"16","author":"Song","year":"2025","journal-title":"Front Immunol"},{"issue":"11","key":"zoi261006r20","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1097\/JS9.0000000000002900","article-title":"Sex disparity of liver cancer recurrence following surgery: sex-determining region Y gene promotes immunosuppressive microenvironment and favors metastasis.","volume":"111","author":"Zhang","year":"2025","journal-title":"Int J Surg"},{"issue":"5","key":"zoi261006r21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.jhep.2020.04.022","article-title":"Liver-related mortality is similar among men and women with cirrhosis.","volume":"73","author":"Mazumder","year":"2020","journal-title":"J Hepatol"},{"issue":"23","key":"zoi261006r22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i23.107100","article-title":"Hepatocellular carcinoma in patients without cirrhosis.","volume":"31","author":"Sato-Espinoza","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"5","key":"zoi261006r23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","article-title":"Liver cancer in 2021: Global Burden of Disease Study.","volume":"82","author":"Tan","year":"2025","journal-title":"J Hepatol"},{"key":"zoi261006r24","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goaf018","article-title":"Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD.","volume":"13","author":"Mi","year":"2025","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"11","key":"zoi261006r25","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000420","article-title":"Changing trends of cirrhotic and noncirrhotic hepatocellular carcinoma in the era of directly-acting antiviral agents.","volume":"12","author":"Mathur","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"zoi261006r26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease.","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"zoi261006r27","doi-asserted-by":"publisher","first-page":"01","DOI":"10.35946\/arcr.v40.2.01","article-title":"Gender differences in the epidemiology of alcohol use and related harms in the United States.","volume":"40","author":"White","year":"2020","journal-title":"Alcohol Res"},{"issue":"4","key":"zoi261006r28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jsat.2006.03.004","article-title":"Alcohol relapse repetition, gender, and predictive validity.","volume":"30","author":"Zywiak","year":"2006","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"zoi261006r29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cgh.2024.10.015","article-title":"Older age but not comorbidity is associated with worse survival in patients with hepatocellular carcinoma.","volume":"23","author":"Kanneganti","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"zoi261006r30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1053\/j.gastro.2019.07.040","article-title":"Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma.","volume":"157","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi261006r31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MEG.0000000000000527","article-title":"Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.","volume":"28","author":"van Meer","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"zoi261006r32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/CH-211309","article-title":"Hepatocellular carcinoma in the non-cirrhotic liver.","volume":"80","author":"Dong","year":"2022","journal-title":"Clin Hemorheol Microcirc"},{"issue":"6","key":"zoi261006r33","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/liv.14087","article-title":"Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.","volume":"39","author":"Bengtsson","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"zoi261006r34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1186\/s12885-019-6167-2","article-title":"Distinct molecular etiologies of male and female hepatocellular carcinoma.","volume":"19","author":"Natri","year":"2019","journal-title":"BMC Cancer"},{"key":"zoi261006r35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","article-title":"Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses?","volume":"9","author":"Ruggieri","year":"2018","journal-title":"Front Immunol"},{"key":"zoi261006r36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1433540","article-title":"Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma.","volume":"15","author":"Su","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"zoi261006r37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3350\/cmh.2020.0203","article-title":"Alcohol and hepatocarcinogenesis.","volume":"26","author":"Taniai","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"zoi261006r38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/HEP.0000000000000277","article-title":"Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review.","volume":"79","author":"Toniutto","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"zoi261006r39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41256-025-00416-y","article-title":"The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021.","volume":"10","author":"Liu","year":"2025","journal-title":"Glob Health Res Policy"},{"issue":"4","key":"zoi261006r40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.24171\/j.phrp.2019.10.4.02","article-title":"Gender differences in harmful use of alcohol among Korean adults.","volume":"10","author":"Park","year":"2019","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"zoi261006r41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12889-019-6502-1","article-title":"Patterns and trends of alcohol consumption in rural and urban areas of China: findings from the China Kadoorie Biobank.","volume":"19","author":"Im","year":"2019","journal-title":"BMC Public Health"},{"issue":"2","key":"zoi261006r42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jvh.13636","article-title":"Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: a large-scale Asian study.","volume":"29","author":"Lee","year":"2022","journal-title":"J Viral Hepat"},{"issue":"2","key":"zoi261006r43","first-page":"401","article-title":"Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.","volume":"70","author":"Nathani","year":"2021","journal-title":"Gut"},{"issue":"5","key":"zoi261006r44","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/hep4.1863","article-title":"Racial, ethnic, and socioeconomic disparities in curative treatment receipt and survival in hepatocellular carcinoma.","volume":"6","author":"Wagle","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"zoi261006r45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.hpb.2024.12.008","article-title":"Next-generation sequencing demonstrates racial and sex differences in genomic profiling of hepatocellular carcinoma patients: an AACR GENIE project analysis.","volume":"27","author":"Tsilimigras","year":"2025","journal-title":"HPB (Oxford)"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854758\/yan_2026_oi_261006_1790346338.63916.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:30:23Z","timestamp":1790955023000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.37313","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}